Blood feud: the man who blew the whistle on one of the deadliest prescription drugs ever

Book Cover
Average Rating
Publisher:
Varies, see individual formats and editions
Pub. Date:
Varies, see individual formats and editions
Language:
English
Description
Blood Feud is the electrifying true tale of Big Pharma's power, regulatory weakness, and the terrifying vulnerability of millions of innocent patients.

THE PLAYERS

The Drug: Procrit An anti-anemia drug, this miraculous blood booster was one of the first biotech blockbusters. Developed by Amgen and licensed to a Johnson & Johnson company, the drug was sold by the two companies under the brand names Procrit, Epogen, and Arenesp.

The Underdog: Mark Duxbury, Drug Salesman Duxbury was the gung-ho salesman for the new biotech division of J&J, an irrepressible character full of jokes. In the early 1990s, he set out to spread the benefits of Procrit, and became a true believer and top seller. But he and his peers were told to steal business from J&J's partner, Amgen. Then came the marketing studies, the off-invoice rebates, doctor payments, and off-label claims. Duxbury tried to stop some of these ruthless programs, but was fired on trumped-up charges. He tried anything to warn the public: testifying in a secret arbitration, joining a class action effort, and filing a whistleblower suit. But he was thwarted at nearly every turn-until the surprising end.

The Best Friend: Dean McClellan, Drug Legend Dean McClellan was Duxbury's friendly rival. He tried to beat his buddy's record and wound up selling $170 million worth of the drug, becoming a legend. When Duxbury got fired, McClellan tried to distance himself. But as news of Procrit's deadly power started to surface, McClellan agreed to hand over thousands of damning documents and help his friend blow the whistle on J&J.

The Crusader: Jan Schlichtmann, Esq. Remember Jan Schlichtmann, protagonist of the best-selling book and Oscar nominated movie, A Civil Action? When he learned of Duxbury's mission, he felt the old fire rising in his belly and signed on. Now, he's gambling on yet another long shot, trying to fight on behalf of not just millions of cancer patients, but for every American who overpays for health-care.

Also in this Series
More Like This
More Copies In Prospector
Loading Prospector Copies...
More Details
ISBN:
9780525952404
9781452623764
Reviews from GoodReads
Loading GoodReads Reviews.
Tagging
Tags:
No Tags, Be the first to tag this record!
Staff View

Grouping Information

Grouped Work ID a9088616-1cea-8082-ea59-ccfab8c92029
Grouping Title blood feud the man who blew the whistle on one of the deadliest prescription drugs ever
Grouping Author sharp kathleen
Grouping Category book
Last Grouping Update 2018-04-05 03:55:24AM
Last Indexed 2018-08-17 04:48:35AM

Solr Details

accelerated_reader_interest_level
accelerated_reader_point_value 0
accelerated_reader_reading_level 0
auth_author2 Marlo, Coleen.
author Sharp, Kathleen.
author2-role Marlo, Coleen., hoopla digital.
author_display Sharp, Kathleen
available_at_loveland Loveland Public Library
detailed_location_loveland Loveland Adult Nonfiction, Online Hoopla Collection
display_description "Blood Feud is the electrifying true tale of Big Pharma's power, regulatory weakness, and the terrifying vulnerability of millions of innocent patients. THE PLAYERS The Drug: Procrit An anti-anemia drug, this miraculous blood booster was one of the first biotech blockbusters. Developed by Amgen and licensed to a Johnson & Johnson company, the drug was sold by the two companies under the brand names Procrit, Epogen, and Arenesp. The Underdog: Mark Duxbury, Drug Salesman Duxbury was the gung-ho salesman for the new biotech division of J&J, an irrepressible character full of jokes. In the early 1990s, he set out to spread the benefits of Procrit, and became a true believer and top seller. But he and his peers were told to steal business from J&J's partner, Amgen. Then came the marketing studies, the off-invoice rebates, doctor payments, and off-label claims. Duxbury tried to stop some of these ruthless programs, but was fired on trumped-up charges. He tried anything to warn the public: testifying in a secret arbitration, joining a class action effort, and filing a whistleblower suit. But he was thwarted at nearly every turn-until the surprising end. The Best Friend: Dean McClellan, Drug Legend Dean McClellan was Duxbury's friendly rival. He tried to beat his buddy's record and wound up selling $170 million worth of the drug, becoming a legend. When Duxbury got fired, McClellan tried to distance himself. But as news of Procrit's deadly power started to surface, McClellan agreed to hand over thousands of damning documents and help his friend blow the whistle on J&J. The Crusader: Jan Schlichtmann, Esq. Remember Jan Schlichtmann, protagonist of the best-selling book and Oscar nominated movie, A Civil Action? When he learned of Duxbury's mission, he felt the old fire rising in his belly and signed on. Now, he's gambling on yet another long shot, trying to fight on behalf of not just millions of cancer patients, but for every American who overpays for. health-care"--Provided by publisher.
format_category_loveland Audio Books, Books, eBook
format_loveland Book, eAudiobook
id a9088616-1cea-8082-ea59-ccfab8c92029
isbn 9780525952404, 9781452623764
item_details hoopla:MWT11186131||Online Hoopla Collection|Online Hoopla|eAudiobook|Audio Books|1|false|true|Hoopla||https://www.hoopladigital.com/title/11186131||Available Online||||, ils:.b19098133|.i40936739|Loveland Adult Nonfiction|338.476153 Sharp, K.|||1|false|false|||||On Shelf||lvnfa||
itype_loveland , hardcover book
last_indexed 2018-08-17T10:48:35.098Z
lexile_score -1
literary_form Non Fiction
literary_form_full Non Fiction
local_callnumber_loveland 338.476153 Sharp, K.
owning_library_loveland Loveland Public Library
owning_location_loveland Loveland Public Library
primary_isbn 9780525952404
publishDate 2011
record_details hoopla:MWT11186131|eAudiobook|Audio Books|Unabridged.|English|Tantor Audio ,|2011.|1 online resource (1 audio file (840 min.)) : digital., ils:.b19098133|Book|Books||English|Dutton/Penguin Group,|c2011.|p. ; cm.
recordtype grouped_work
scoping_details_loveland
Bib IdItem IdGrouped StatusStatusLocally OwnedAvailableHoldableBookableIn Library Use OnlyLibrary OwnedHoldable PTypesBookable PTypesLocal Url
hoopla:MWT11186131 Available Online Available Online false true false false false false
ils:.b19098133 .i40936739 On Shelf On Shelf false true true false false true 128, 129, 1, 130, 2, 3, 131, 4, 133, 5, 6, 7, 135, 8, 136, 9, 10, 11, 12, 13, 17, 18, 19, 20, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 45, 46, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 80, 81, 82, 84, 85, 86, 92, 93, 95, 96, 97, 98, 99, 100, 105, 106, 108, 109, 110, 117, 118, 119, 125, 126, 127
subject_facet Amgen Inc, Anemia -- Drug therapy -- United States, Duxbury, Mark, Epoetin Alfa -- Adverse effects -- United States, Epoetin Alfa -- Economics -- United States, Johnson and Johnson, inc, Marketing of Health Services -- Economics -- United States, McClellan, Dean, Pharmaceutical industry -- Corrupt practices -- United States, Pharmaceutical industry -- Economics -- United States, Schlichtmann, Jan, Whistle blowing -- United States -- Case studies, Whistleblowing -- United States
title_display Blood feud : the man who blew the whistle on one of the deadliest prescription drugs ever
title_full Blood feud : the man who blew the whistle on one of the deadliest prescription drugs ever / Kathleen Sharp, Blood feud : the man who blew the whistle on one of the deadliest prescription drugs ever [electronic resource] / Kathleen Sharp
title_short Blood feud :
title_sub the man who blew the whistle on one of the deadliest prescription drugs ever
topic_facet Adverse effects, Anemia, Corrupt practices, Drug therapy, Duxbury, Mark, Economics, Epoetin Alfa, Marketing of Health Services, McClellan, Dean, Pharmaceutical industry, Schlichtmann, Jan, Whistle blowing, Whistleblowing